Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives.
Nadkarni
V D
VD
Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa, Iowa City 52242, USA.
Toida
T
T
Van Gorp
C L
CL
Schubert
R L
RL
Weiler
J M
JM
Hansen
K P
KP
Caldwell
E E
EE
Linhardt
R J
RJ
D002240:Carbohydrate Sequence; D002809:Chondroitin Sulfates / Q000378:metabolism* / Q000494:pharmacology*; D003169:Complement Inactivator Proteins / Q000138:chemical synthesis / Q000494:pharmacology; D003871:Dermatan Sulfate / Q000378:metabolism* / Q000494:pharmacology*; D065427:Factor Xa Inhibitors; D006025:Glycosaminoglycans / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D009682:Magnetic Resonance Spectroscopy; D008969:Molecular Sequence Data; D015394:Molecular Structure; D011516:Prothrombin / Q000037:antagonists & inhibitors; D013449:Sulfonamides / Q000138:chemical synthesis* / Q000494:pharmacology
D003169:Complement Inactivator Proteins; D065427:Factor Xa Inhibitors; D006025:Glycosaminoglycans; D013449:Sulfonamides; D003871:Dermatan Sulfate; D011516:Prothrombin; C025337:Factor IIa; D002809:Chondroitin Sulfates